Fiche publication
Date publication
juillet 2018
Journal
PharmacoEconomics
Auteurs
Lien Pubmed
Résumé
The place of disease-modifying osteoarthritis drugs (DMOADs) and intra-articular hyaluronic acid (IAHA) in the therapeutic arsenal for knee osteoarthritis (OA) remains uncertain. Indeed, these treatments have demonstrated symptomatic efficacy but no efficacy for disease modification.
Référence
Pharmacoeconomics. 2018 Jul 26;:
